Browsing by Author "Coelho, Rowena Alves"
Now showing items 1-19 of 19
-
A case-series of bloodstream infections caused by the Meyerozyma guilliermondii species complex at a reference center of oncology in Brazil
Chaves, Alessandra Leal Silva et al. | Date Issued: 2020 -
Chromoblastomycosis: relationships between laboratorial and clinical data of 12 patients from Rio de Janeiro, Brazil
Almeida-Paes, Rodrigo et al. | Date Issued: 2018 -
Cromoblastomicose: Principais agentes, diagnóstico micológico, susceptibilidade in vitro aos fármacos antifúngicos
Coelho, Rowena Alves | Date Issued: 2019 -
Cryptococcosis due to Cryptococcus gattii VGII in southeast Brazil: the one health approach revealing a possible role for domestic cats
Brito-Santos, Fábio et al. | Date Issued: 2019 -
Does DHN-Melanin Always Protect Fungi against Antifungal Drugs? The Fonsecaea/Micafungin Paradigm
Coelho, Rowena Alves et al. | Date Issued: 2022 -
Evaluation of new potential compounds for the treatment of chromoblastomycosis
Coelho, Rowena Alves et al. | Date Issued: 2019 -
Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome
Cruz, Ingrid Ludmila Rodrigues et al. | Date Issued: 2021 -
Fatal septic shock caused by Paracoccidioides brasiliensis phylogenetic species S1 in a young immunocompetent patient: a case report
Macedo, Priscila Marques de et al. | Date Issued: 2018 -
Mebendazole inhibits Histoplasma capsulatum in vitro growth and decreases mitochondrion and cytoskeleton protein levels
Almeida, Marcos Abreu et al. | Date Issued: 2023 -
Metabolic and phenotypic plasticity may contribute for the higher virulence of Trichosporon asahii over other Trichosporonaceae members
Andrade, Iara Bastos de et al. | Date Issued: 2023 -
Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil
Coelho, Rowena Alves et al. | Date Issued: 2018 -
Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil
Brito-Santos, Fabio et al. | Date Issued: 2020 -
New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole
Coelho, Rowena Alves et al. | Date Issued: 2022 -
Paracoccidioidomycosis due to Paracoccidioides brasiliensis S1 plus HIV co-infection
Macedo, Priscila Marques de et al. | Date Issued: 2018 -
Preservation methods in isolates of Sporothrix characterized by polyphasic approach
Rabello, Vanessa Brito de Souza et al. | Date Issued: 2023 -
Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole
Coelho, Rowena Alves et al. | Date Issued: 2023 -
A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis
Coelho, Rowena Alves et al. | Date Issued: 2020 -
Susceptibilidade de Fonsecaea spp. aos antifúngicos: relações com a produção de melanina fúngica, associação de fármacos e aspectos clínicos dos pacientes
Coelho, Rowena Alves | Date Issued: 2017A cromoblastomicose (CBM) é uma micose crônica que afeta a pele, tecidos subcutâneos e apresenta distribuição global, com predominância em áreas rurais de países tropicais e subtropicais. No Brasil, o gênero Fonsecaea é o ... -
Tinea Capitis by Microsporum audouinii: Case Reports and Review of Published Global Literature 2000-2016
Brito-Santos, Fábio et al. | Date Issued: 2017